drugset / Trial / NCT02791243

Photosensitization Study in Androgenetic Alopecia

NCT02791243

Phase 1 Completed 58 enrolled Polichem S.A.
RandomizedFactorialTriple-blindTreatment

Summary

This study evaluates the potential for induction of photosensitization by P-3074 0.25% finasteride cutaneous solution compared to that of placebo vehicle cutaneous solution and a negative control (0.9% sodium chloride, NaCl)

Timeline

Start
2016-05-09
Primary completion
2016-06
Completion
2016-06-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Finasteride Small molecule 0.2 ml Topical
Subject Finasteride Small molecule 0.25 % Topical

Indications